Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05736614 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimizing PrEP Uptake and Adherence Among Male Sex Workers

Study acronym: P4W
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jun 2026 → Jun 2027
See other at-risk trials from Brown University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 2026 to Jun 2027 Show 8 more changesShow less
    • Enrollment closed, study ongoing
    • Study completion pushed from Jun 2026 to Aug 2027
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description revised
    • Site details revised at 5 of 5 sites
    • Collaborators: details revised at 1 of 5 entries
    • Publications: details revised at 1 of 1 entry
  2. Site contacts updated at 3 of 5 sitesv3
  3. Start date: Nov 21, 2022 to Nov 3, 2022v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
"PrEPare for Work" is a randomized controlled trial (RCT) whose goal is to test the efficacy of a behavioral intervention (Short Title: PrEPare for Work) in improving PrEP uptake, adherence, and persistence among male sex workers (MSW)
Trial Details
NCT Number NCT05736614
Lead Sponsor Brown University
Collaborators: The Miriam Hospital, University of California, Los Angeles, Project Weber/RENEW, Open Door Health, National Institute of Nursing Research (NINR)
Conditions
(from sponsor)		 Prevention
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov